Pharma Focus Asia
KP - Sustainable Packaging Solutions

Zydus and Mayne build new plant to manufacture oncology products in India

Zydus Cadila and Mayne Pharma, an injectable specialty pharmaceuticals company based in Australia signed a joint venture agreement to set up a 50:50 joint venture company to manufacture generic injectable, cytotoxic (anti-cancer) medicines and active pharmaceutical ingredients (API) for global markets.

The two companies will share equally the investment in construction and validation costs of the new facility and will share in the profits of the joint venture. Both companies will also have equal representation on the JV's board of directors. The plant will manufacture both solution and freeze-dried products and have a maximum capacity of approximately 10-12 million vials per annum.

The new facility will be set up in Gujarat, India. Construction of the new facility began in the second quarter of 2005 and, following regulatory approval, the first set of products is expected to be launched in fiscal year 2008. The products will be marketed globally by both companies in different territories.

Initially, the joint venture will focus on a defined range of generic, injectable cytotoxic medicines where there is an opportunity to capitalise on both the development and manufacturing benefits available in India, as well as capturing potential vertical integration benefits that will come with the internal production of the API. Over time, both companies will assess opportunities to manufacture other generic injectable cytotoxic products at this facility.

The joint venture allows Mayne to diversify its manufacturing capabilities, improve its speed to market and address future capacity requirements. This plant will almost double Mayne Pharma's cytotoxic manufacturing capabilities and assist with early development and launch of products at patent expiry in key target markets. Zydus Cadila, which has forged several partnerships and alliances, gains a partner with expertise in manufacturing and marketing of injectable oncology products and other specialty products in the global market.

Specifications Table:

  • Company Name
  • Zydus Cadila and Mayne Pharma
  • Location
  • Gujarat, India
  • Plant Type
  • To manufacture oncology products
  • Date of Start
  • 2005
  • Date of Completion
  • 2008
  • Estimated Investment
  • Not Available
  • Key players
  • Sponsors/Partners
  • Zydus Cadila and Mayne Pharma
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?